Novavax, Inc. (NVAX)
NASDAQ: NVAX · Real-Time Price · USD
9.43
-0.58 (-5.79%)
Mar 19, 2026, 11:44 AM EDT - Market open

Novavax Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
1,5361,0931,29067088410,851
Market Cap Growth
24.38%-15.29%92.61%-24.29%-91.85%37.14%
Enterprise Value
1,079603.73590.08325.06-254.699,659
Last Close Price
9.436.728.044.8010.28143.07
PE Ratio
3.892.60-6.54-0.89-1.22-6.10
Forward PE
-----10.46
PS Ratio
1.370.971.890.680.459.47
PB Ratio
--8.55-2.07-0.93-1.39-30.85
P/TBV Ratio
-12.78-9.10-1.96-0.67-1.27-30.27
P/FCF Ratio
--4.37-12.86-0.87-1.7540.42
P/OCF Ratio
--4.47-14.78-0.94-2.1333.60
EV/Sales Ratio
0.960.540.870.33-0.138.43
EV/EBITDA Ratio
1.831.26-2.94-0.620.41-5.77
EV/EBIT Ratio
1.921.33-2.37-0.570.40-5.73
EV/FCF Ratio
--2.41-5.88-0.420.5035.98
Debt / Equity Ratio
-1.93-1.93-0.36-0.31-0.31-0.92
Debt / EBITDA Ratio
0.520.52-1.15-0.44-0.89-0.27
Debt / FCF Ratio
-0.99-0.99-2.30-0.30-1.091.69
Net Debt / Equity Ratio
3.813.811.110.471.243.02
Net Debt / EBITDA Ratio
-1.01-1.013.460.651.280.63
Net Debt / FCF Ratio
1.941.946.910.441.56-3.95
Asset Turnover
0.820.820.410.490.820.55
Inventory Turnover
7.207.208.048.7739.630
Quick Ratio
1.831.830.890.530.580.82
Current Ratio
2.132.130.980.700.690.90
Return on Equity (ROE)
-117.16%-117.16%27.97%80.69%133.49%-1265.72%
Return on Assets (ROA)
33.23%33.23%-13.91%-27.83%-26.49%-79.72%
Return on Invested Capital (ROIC)
130.99%130.99%-43.01%-138.36%-341.62%-352.52%
Return on Capital Employed (ROCE)
80.67%80.67%-87.60%2911.68%8694.44%-283.64%
Earnings Yield
28.66%38.39%-15.30%-112.71%-81.91%-16.38%
FCF Yield
-16.28%-22.90%-7.78%-114.65%-57.09%2.47%
Buyback Yield / Dilution
0.44%0.44%-20.51%-53.82%-28.11%-5.43%
Updated Feb 26, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q